+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Sepsis Diagnostic Market by Testing Type (Laboratory Testing, PoC Testing), Technology (Flow Cytometry, Immunoassays, Microbiology), Product, Method, Pathogen, End-user - Forecast 2024-2030- Product Image
Global Sepsis Diagnostic Market by Testing Type (Laboratory Testing, PoC Testing), Technology (Flow Cytometry, Immunoassays, Microbiology), Product, Method, Pathogen, End-user - Forecast 2024-2030- Product Image
Sale

Global Sepsis Diagnostic Market by Testing Type (Laboratory Testing, PoC Testing), Technology (Flow Cytometry, Immunoassays, Microbiology), Product, Method, Pathogen, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5311190
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sepsis Diagnostic Market size was estimated at USD 556.86 million in 2023, USD 611.80 million in 2024, and is expected to grow at a CAGR of 9.98% to reachUSD 1.08 billion by 2030.

Sepsis is a condition that arises from the body's reaction to an infection that causes injury to its tissues and organs; thus, sepsis diagnostics are essential for the timely and accurate detection of sepsis, leading to immediate and appropriate treatment interventions. There is an increasing need for sepsis diagnostics, as they are critical in saving lives, preventing disease progression, reducing healthcare costs, and enhancing the quality of life for patients impacted by sepsis. The growing number of sepsis cases globally due to rising infection rates, aging populations, and higher susceptibility in individuals with chronic diseases has led to an increasing need for efficient diagnostic methods. Improved healthcare infrastructure, particularly in developing countries, along with better healthcare policies and increased healthcare spending, supports the growth of the sepsis diagnostic market. However, the lack of awareness and understanding of sepsis in several underdeveloped regions limits the need for diagnostic solutions. Nevertheless, advances in technology that offer the potential to reduce diagnosis time and improve patient outcomes are expected to create opportunities for the adoption of sepsis diagnostics solutions.

Regional Insights

In the Americas, particularly in North America, the sepsis diagnostics market is witnessing significant growth, growing healthcare facilities, heightened awareness about sepsis, and substantial investment in research and diagnostic technologies. South America is seeing improvements in healthcare access and an increasing emphasis on early diagnosis and treatment, driving the need for sepsis diagnostics. Asia-Pacific region represents an emerging sepsis diagnostics market, propelled by its large population, elevating healthcare expenditure, and growing awareness of sepsis as a critical health issue. Countries in the Asia-Pacific are benefiting from governmental healthcare reforms and investments in healthcare infrastructure, causing a significant adoption of advanced sepsis diagnostics solutions. The Europe, Middle East, and Africa region presents a varied landscape for the sepsis diagnostics market. Europe noticed strong growth driven by well-established healthcare systems, high healthcare spending, and stringent regulatory standards promoting the adoption of advanced diagnostics.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Sepsis Diagnostic Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing Incidence and Prevalence of Sepsis
  • Growing Occurrence of Hospital Derived Infections
  • Development of Technology Advanced Diagnostic Solutions

Market Restraints

  • Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations

Market Opportunities

  • Emerging Development of Rapid Diagnostics Globally
  • Development of Novel Biomarkers for Sepsis Diagnostics

Market Challenges

  • Lack of Awareness and Standard Protocols for the Procedure

Market Segmentation Analysis

  • Testing Type: Increasing usage of PoC testing solutions for sepsis diagnostics
  • End-user: Emerging use of advanced sepsis diagnostics solutions in pathology and reference laboratories

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Sepsis Diagnostic Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Sepsis Diagnostic Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Unveiling of FDA-Authorized AI Tool by Prenosis, Inc.

Prenosis, Inc. achieves a monumental milestone with the FDA’s marketing authorization of the Sepsis ImmunoScore, marking the debut of an AI-driven diagnostic tool for sepsis. With this FDA authorization, Prenosis underscores its dedication to transforming acute care through precision medicine, heralding a new era in personalized healthcare solutions driven by AI diagnostics.

Innovative AI-Powered Early Detection of Sepsis by Presymptom Health Secures GBP 1.5 Million in Funding

Presymptom Health secured GBP 1.5 million in a combination of equity and grant funding, reflecting the potential of its AI and machine learning technologies to revolutionize early infection detection. Leveraging vast biobank data, Presymptom Health's advanced analytics can identify signs of infections and sepsis significantly earlier than traditional methods, potentially days before clinical symptoms become apparent. This funding round, featuring contributions from UKI2S, Ploughshare, and MedTechToMarket along with Innovate UK grants, underscores AI's significant advances and the promise in healthcare, especially for conditions including sepsis that need swift intervention.

Cytovale's Strategic Advancement with USD 84 Million Series C Funding

Medical technology firm Cytovale made a stride in sepsis diagnosis with its innovative test, IntelliSep, through an USD 84 million Series C funding round. This funding aims to tackle the pressing issue of delayed sepsis diagnosis, which incurs an annual cost of USD 62 billion nationwide.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Sepsis Diagnostic Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Sepsis Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alifax S.r.l., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Boditech Med Inc., Bruker Corporation, CytoSorbents Corporation, DiaSorin S.p.A., EKF Diagnostics, F. Hoffmann-La Roche AG, Immunexpress Inc., Koninklijke Philips N.V., McKesson Corporation, Nanomix Inc., Oracle Corporation, Response Biomedical Corporation, Seegene Inc., Siemens Healthineers, T2 Biosystems, Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Sepsis Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Testing Type

  • Laboratory Testing
  • PoC Testing

Technology

  • Flow Cytometry
  • Immunoassays
  • Microbiology
  • Molecular Diagnostics

Product

  • Assay Kits and Reagents
  • Blood Culture Media
  • Instruments
  • Software

Method

  • Automated Diagnostics
  • Conventional Diagnostics
  • Pathogen

Bacterial Sepsis

  • Gram-Negative Bacteria
  • Gram-Positive Bacteria
  • Fungal Sepsis

End-user

  • Hospitals
  • Pathology & Reference Laboratories
  • Research Laboratories & Academic Institutes

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence and Prevalence of Sepsis
5.1.1.2. Growing Occurrence of Hospital Derived Infections
5.1.1.3. Development of Technology Advanced Diagnostic Solutions
5.1.2. Restraints
5.1.2.1. Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
5.1.3. Opportunities
5.1.3.1. Emerging Development of Rapid Diagnostics Globally
5.1.3.2. Development of Novel Biomarkers for Sepsis Diagnostics
5.1.4. Challenges
5.1.4.1. Lack of Awareness and Standard Protocols for the Procedure
5.2. Market Segmentation Analysis
5.2.1. Testing Type: Increasing usage of PoC testing solutions for sepsis diagnostics
5.2.2. End-user: Emerging use of advanced sepsis diagnostics solutions in pathology and reference laboratories
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Sepsis Diagnostic Market, by Testing Type
6.1. Introduction
6.2. Laboratory Testing
6.3. PoC Testing
7. Sepsis Diagnostic Market, by Technology
7.1. Introduction
7.2. Flow Cytometry
7.3. Immunoassays
7.4. Microbiology
7.5. Molecular Diagnostics
8. Sepsis Diagnostic Market, by Product
8.1. Introduction
8.2. Assay Kits and Reagents
8.3. Blood Culture Media
8.4. Instruments
8.5. Software
9. Sepsis Diagnostic Market, by Method
9.1. Introduction
9.2. Automated Diagnostics
9.3. Conventional Diagnostics
10. Sepsis Diagnostic Market, by Pathogen
10.1. Introduction
10.2. Bacterial Sepsis
10.3. Fungal Sepsis
11. Sepsis Diagnostic Market, by End-user
11.1. Introduction
11.2. Hospitals
11.3. Pathology & Reference Laboratories
11.4. Research Laboratories & Academic Institutes
12. Americas Sepsis Diagnostic Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Sepsis Diagnostic Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Sepsis Diagnostic Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Unveiling of FDA-Authorized AI Tool by Prenosis, Inc.
15.3.2. Innovative AI-Powered Early Detection of Sepsis by Presymptom Health Secures GBP 1.5 Million in Funding
15.3.3. Cytovale's Strategic Advancement with USD 84 Million Series C Funding
15.4. Strategy Analysis & Recommendation
16. Competitive Portfolio
16.1. Key Company Profiles
16.2. Key Product Portfolio
List of Figures
FIGURE 1. SEPSIS DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. SEPSIS DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SEPSIS DIAGNOSTIC MARKET DYNAMICS
FIGURE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2023 VS 2030 (%)
FIGURE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 28. SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SEPSIS DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AUTOMATED DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY AUTOMATED DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 104. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 105. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 110. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 111. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 112. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 113. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 114. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 115. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 118. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 119. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 120. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 121. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 124. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 125. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 126. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 127. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 128. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 129. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 165. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 166. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 167. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 178. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 179. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 184. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 185. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 186. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 187. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 188. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 189. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 192. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 193. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 198. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 199. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 200. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 201. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 202. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 203. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 206. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 207. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 208. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 209. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 210. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 220. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 221. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 226. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 227. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 228. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 229. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 230. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 231. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 234. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 235. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 248. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 249. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 250. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 251. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 262. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 263. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 264. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 265. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 268. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 276. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 277. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 282. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 290. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 291. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 296. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 304. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 305. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 306. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 307. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 308. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 309. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 310. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 311. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 312. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 313. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 314. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 315. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 316. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 317. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 318. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 319. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 322. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 323. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 324. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 325. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 326. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 327. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 328. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 329. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 330. VIETNAM SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2024-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 347. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2023 (USD MILLION)
TABLE 348. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2024-2030 (USD MILLION)
TABLE 349. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 350. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 351. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 354. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 355. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2023 (USD MILLION)
TABLE 356. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2024-2030 (USD MILLION)
TABLE 357. DENMARK SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2023 (USD MILLION)
TABLE 358. DENMARK SEPSIS DIAGNOS

Companies Mentioned

  • Abbott Laboratories
  • Alifax S.r.l.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Boditech Med Inc.
  • Bruker Corporation
  • CytoSorbents Corporation
  • DiaSorin S.p.A.
  • EKF Diagnostics
  • F. Hoffmann-La Roche AG
  • Immunexpress Inc.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Nanomix Inc.
  • Oracle Corporation
  • Response Biomedical Corporation
  • Seegene Inc.
  • Siemens Healthineers
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.
  • Wolters Kluwer N.V.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 611.8 Million
Forecasted Market Value ( USD ) by 2030 $ 1084.17 Million
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Global Sepsis Diagnostics Market Size, Share & Trends Analysis Report by Product (Assay Kits & Reagents, Blood Culture Media), Technology, Pathogen, Testing Type, Method, End-user, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Sepsis Diagnostics Market Size, Share & Trends Analysis Report by Product (Assay Kits & Reagents, Blood Culture Media), Technology, Pathogen, Testing Type, Method, End-user, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Global Sepsis Diagnostics Market Size By Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Forecast to 2029 - Product Image

Global Sepsis Diagnostics Market Size By Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Forecast to 2029

  • Report
  • 264 Pages
  • Global
From
Global Sepsis Diagnostics Market Analysis & Forecast to 2023-2033: Market By Product; By Technology; By Method; By Pathogen; By Testing; By End-user; and By Region - Product Image

Global Sepsis Diagnostics Market Analysis & Forecast to 2023-2033: Market By Product; By Technology; By Method; By Pathogen; By Testing; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Sepsis Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Sepsis Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Global Sepsis Diagnostics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Sepsis Diagnostics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.